Published in Lancet on November 25, 2006
A withdrawn prepublication. Lancet (2007) 0.96
A withdrawn prepublication. Lancet (2007) 0.95
A withdrawn prepublication. Lancet (2007) 0.75
The natural history of invasive breast cancers detected by screening mammography. Arch Intern Med (2008) 7.37
Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study. BMJ (2004) 4.94
Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ (2010) 2.99
Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain (2006) 2.85
[Overdiagnosis in mammography screening]. Tidsskr Nor Laegeforen (2004) 2.67
Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors. Acta Radiol (2010) 2.26
Brain pathology in fatal serotonin syndrome: presentation of two cases. Neuropathology (2010) 1.44
Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control (2011) 1.41
Norwegian mammography screening - numerous self-contradictions in the evaluation. Tidsskr Nor Laegeforen (2016) 1.38
Overdiagnosis in organised mammography screening in Denmark. A comparative study. BMC Womens Health (2009) 1.35
Biases in estimates of overdetection due to mammography screening. Lancet Oncol (2008) 1.24
Spontaneous regression of cancerous tumors detected by mammography screening. JAMA (2004) 1.20
Flawed inferences about screening mammography's benefit based on observational data. J Clin Oncol (2008) 1.17
IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS One (2009) 1.11
Influence of mammography screening on use of mastectomies in Denmark. Acta Oncol (2014) 1.05
Social inequalities in mortality: changes in the relative importance of income, education and household size over a 27-year period. Eur J Public Health (2005) 1.01
A decline in breast-cancer incidence. N Engl J Med (2007) 1.01
An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts. BMC Cancer (2011) 0.99
Is birth history the key to highly educated women's higher breast cancer mortality? A follow-up study of 500,000 women aged 35-54. Int J Cancer (2005) 0.98
Neuropathological findings in 9 cases of listeria monocytogenes brain stem encephalitis. Brain Pathol (2005) 0.97
Chain of care for patients who have attempted suicide: a follow-up study from Bærum, Norway. BMC Public Health (2011) 0.94
Low-potency glucocorticoid hydrocortisone has similar neurotoxic effects as high-potency glucocorticoid dexamethasone on neurons in the immature chicken cerebellum. Brain Res (2008) 0.93
Fatal subarachnoidal haemorrhage in a Norwegian traveller with dengue virus infection. Scand J Infect Dis (2007) 0.93
Reduction in mortality from breast cancer: decrease with screening was marked in younger age group. BMJ (2005) 0.92
Allele frequencies of apolipoprotein E gene polymorphisms in the protein coding region and promoter region (-491A/T) in a healthy Norwegian population. Hum Biol (2002) 0.89
Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ (2011) 0.88
Brain stem encephalitis in listeriosis. Scand J Infect Dis (2005) 0.87
Breast cancer awareness month. Still awaiting screening facts. BMJ (2010) 0.86
Changes in mental health services and suicide mortality in Norway: an ecological study. BMC Health Serv Res (2011) 0.85
Tuberculin status, socioeconomic differences and differences in all-cause mortality: experience from Norwegian cohorts born 1910-49. Int J Epidemiol (2009) 0.85
Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway. Breast J (2012) 0.81
Changes in institutional psychiatric care and suicidal behaviour: a follow-up study of inpatient suicide attempters in Baerum, Norway. Soc Psychiatry Psychiatr Epidemiol (2009) 0.81
The benefits and harms of breast cancer screening. Lancet (2013) 0.81
Breast screening: why estimates differ by a factor of 20-25. J Med Screen (2010) 0.79
Listeriosis in Norway 1977-2003. Scand J Infect Dis (2007) 0.79
Do model results suggest spontaneous regression of breast cancer? Int J Cancer (2006) 0.77
The apolipoprotein E polymorphism and cardiovascular diseases--an autopsy study. Cardiovasc Pathol (2012) 0.77
Model of outcomes of screening mammography: spontaneous regression of breast cancer may not be uncommon. BMJ (2005) 0.77
Overdiagnosis of invasive breast cancer due to mammography screening. Ann Intern Med (2012) 0.77
The Two-County breast screening trial cannot provide a reliable estimate of the effect of breast cancer screening. Radiology (2012) 0.76
Unaltered lactate and glucose transporter levels in the MPTP mouse model of Parkinson's disease. J Parkinsons Dis (2013) 0.76
[Better more than fewer autopsies]. Tidsskr Nor Laegeforen (2010) 0.75
Bias when calculating breast cancer mortality after screening mammography in British Colombia. Int J Cancer (2007) 0.75
Constant relative survival rates in Sweden and Norway when adjusting for screening-related overdiagnosis. Int J Cancer (2007) 0.75
[No significant effect of PSA screening]. Tidsskr Nor Laegeforen (2013) 0.75
[P-H. Zahl replies]. Tidsskr Nor Laegeforen (2013) 0.75
[Re: Melanoma incidence on the rise again]. Tidsskr Nor Laegeforen (2015) 0.75
[Re: Mammography screening should be discontinued]. Tidsskr Nor Laegeforen (2014) 0.75
[No effect of organized cervix cancer screening]. Tidsskr Nor Laegeforen (2008) 0.75
Undeclared motives in withdrawing a publication. Lancet (2007) 0.75
Ramifications of screening for breast cancer: definition of overdiagnosis is confusing in follow-up of Malmö trial. BMJ (2006) 0.75
[Is overdiagnosing with 50 percent in mammography screening acceptable?]. Tidsskr Nor Laegeforen (2007) 0.75
Tidsskr Nor Laegeforen (2016) 0.75
More on screening mammography. N Engl J Med (2011) 0.75
Declining breast cancer incidence and decreased HRT use. Lancet (2009) 0.75
[Re: Why are results of organised mammography screening so difficult to interpret?]. Tidsskr Nor Laegeforen (2014) 0.75
[Estrogen replacement therapy and breast cancer]. Tidsskr Nor Laegeforen (2005) 0.75
Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics. Dan Med Bull (2006) 0.75
Preconditioning with estradiol abolishes its neuroprotection in cerebellar neurons. Biochem Biophys Res Commun (2006) 0.75
[Does organized mammographic screening reduce the breast cancer mortality?]. Tidsskr Nor Laegeforen (2002) 0.75
Brain infection with Staphylococcus aureus leads to high extracellular levels of glutamate, aspartate, γ-aminobutyric acid, and zinc. J Neurosci Res (2014) 0.75
Chicken cerebellar granule neurons rapidly develop excitotoxicity in culture. J Neurosci Methods (2006) 0.75
[Breast cancer mortality versus breast cancer survival]. Tidsskr Nor Laegeforen (2010) 0.75